C41H67NO15
Neat
813.98
Leucomycin A4; 18361-46-1; BP88W7ZP3A; DTXSID501317663; [(2S, 3S, 4R, 6S)-6-[(2R, 3S, 4R, 5R, 6S)-6-[[(4R, 5S, 6S, 7R, 9R, 10R, 11E, 13E, 16R)-4-acetyloxy-10-hydroxy-5-methoxy-9, 16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11, 13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2, 4-dimethyloxan-3-yl] butanoate; ((2S, 3S, 4R, 6S)-6-((2R, 3S, 4R, 5R, 6S)-6-(((4R, 5S, 6S, 7R, 9R, 10R, 11E, 13E, 16R)-4-acetyloxy-10-hydroxy-5-methoxy-9, 16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11, 13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl)oxy-4-hydroxy-2, 4-dimethyloxan-3-yl) butanoate; RefChem:153089; GlyTouCan:G68860RY; DTXCID701747468; G68860RY; Leukomycin A4; Josamycin EP Impurity A; UNII-BP88W7ZP3A; BRN 1678667; KITASAMYCIN A4; Leucomycin V and 3-acetate 4(sup B)-butanoate; orb1692139; CHEMBL3251852; SCHEMBL30405910; CHEBI:34814
[(2S, 3S, 4R, 6S)-6-[(2R, 3S, 4R, 5R, 6S)-6-[[(4R, 5S, 6S, 7R, 9R, 10R, 11E, 13E, 16R)-4-acetyloxy-10-hydroxy-5-methoxy-9, 16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11, 13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2 and 4-dimethyloxan-3-yl] butanoate
InChI=1S/C41H67NO15/c1-11-15-31(46)55-39-26(5)52-33(22-41(39,7)49)56-36-25(4)53-40(35(48)34(36)42(8)9)57-37-28(18-19-43)20-23(2)29(45)17-14-12-13-16-24(3)51-32(47)21-30(38(37)50-10)54-27(6)44/h12-14,17,19,23-26,28-30,33-40,45,48-49H,11,15-16,18,20-22H2,1-10H3/b13-12+,17-14+/t23-,24-,25-,26+,28+,29+,30-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1